REN and atherosclerosis: Previous studies have shown that renin-angiotensin system antagonists could decrease cardiovascular events and mortality in stable CAD patients (25, 26), and in the present study, the degree of atherosclerosis was significantly suppressed in mice after 7 months of ACEI administration.